Zagorski Andrei Yuryevich

Zagorski Andrei Yuryevich

Education

Andrei Zagorski graduated from Far Eastern State University, an MBA program at the Stockholm School of Economics.

Career

2008-2016

He gained managerial experience in leadership positions in large oil, energy companies and retail.

2008-2010 - General Director of Yakutgazprom OJSC (YATEK).

2011-2014 - development of the Nevada group of companies.

2014-2016 - Head of projects for the modernization of the port of Zarubino and the coal terminal in the port of Vostochny Fesco Group.

2016-2018

Since 2016, he worked as the general director of the management company ZAO Pharm-Center, was engaged in the development of the Kurgan plant Sintez, Stavropol Biokoma, and since May 2017, Ryazan Fort.

On August 25, 2017, Rostec State Corporation announced personnel changes in the National Immunobiological Company, which unites enterprises of the domestic pharmaceutical industry. Andrei Zagorski has been appointed interim general director of the holding, who is leaving the post of general director of the Farm Center management company.

The new leader faces tasks related to further increasing the economic efficiency of the holding's enterprises.

Since February 28, 2018, he joined the Board of Directors of the pharmaceutical holding Natsimbio. Read more here.

2023: Appointment as CEO of Natsimbio

In November 2023, the pharmaceutical holding Natsimbio"," part of the state corporation Rostec"," announced the appointment of Andrei Zagorski as the new general director. Previously, he led the company as acting general director.

In recent years, under the leadership of Andrei Zagorski, our holding has brought to the market many new popular drugs, improved financial indicators, while ensuring the supply of vaccines for the National Calendar of Preventive Vaccinations (NCPP) and against COVID-19 at the federal level. We look forward to further strengthening the company's position in all strategic areas of activity, - said Rostec.

Andrei Zagorski headed Natsimbio

By November 2023, Natsimbio is the largest producer of vaccines Russia for the NCPP. Since 2015, the holding has supplied more than 1 billion vaccines to state medical institutions. Natsimbio includes the research and production association Microgene"," as well as the biopharmaceutical company "" Fort(a total of 10 production sites).